Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

674
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
674
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

516
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
516
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

606
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Performance of Prespecified OCT Rules for Glaucomatous Optic Neuropathy in Nonpathologic Myopia.

JAMA ophthalmology·2026
Same author

A Graph Neural Network-Based Multispectral-View Learning Model for Diabetic Macular Ischemia Detection From Color Fundus Photographs.

Translational vision science & technology·2026
Same author

An AI-Based OCT System to Detect Diabetic Macular Edema: A Prospective Validation and Noninferiority Randomized Clinical Trial.

JAMA·2026
Same author

Artificial intelligence-based retinal imaging for brain health assessment: a scoping review.

The Lancet. Digital health·2026
Same author

AI-Driven Oculomics-The Brain-Retina Connection.

JAMA ophthalmology·2026
Same authorSame journal

Corrigendum to "Oculomics and AI: The eye as a biomarker for health span" [Asia-Pac J Ophthalmol 15 (1) (2026) 100282].

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Related Experiment Video

Updated: Aug 12, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K

Applications of Artificial Intelligence and Deep Learning in Glaucoma.

Dinah Chen1,2, An Ran Ran3,4, Ting Fang Tan5,6

  • 1Department of Ophthalmology, NYU Langone Health, New York City, NY.

Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|January 27, 2023
PubMed
Summary

Artificial intelligence (AI) shows promise for glaucoma assessment, but challenges like data scarcity and varied diagnostic criteria hinder clinical tool development. Current AI primarily uses single imaging types, with limited research on treatment response prediction.

More Related Videos

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

2.9K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.4K

Related Experiment Videos

Last Updated: Aug 12, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

2.9K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.4K

Area of Science:

  • Ophthalmology and Medical Imaging
  • Artificial Intelligence in Healthcare

Background:

  • Glaucoma diagnosis and progression detection are complex clinical challenges.
  • Existing artificial intelligence (AI) tools for glaucoma often focus on single imaging modalities, limiting comprehensive assessment.
  • Development of AI algorithms is hampered by the multimodal nature of glaucoma diagnosis and data variability.

Purpose of the Study:

  • To review the current landscape of AI applications in glaucoma diagnosis, progression, and treatment.
  • To identify limitations and challenges in developing and implementing AI tools for glaucoma care.
  • To highlight areas for future research in AI for glaucoma.

Main Methods:

  • Literature search for studies on AI in glaucoma.
  • Analysis of AI algorithm focus (e.g., fundus photos, OCT, visual fields).
  • Assessment of AI application scope (diagnosis, progression, treatment response, prospective testing).

Main Results:

  • Most AI algorithms concentrate on single imaging modalities (fundus photos, OCT) for screening and diagnosis.
  • AI for disease progression prediction predominantly relies on visual field data.
  • No studies were found using AI for treatment response prediction or prospective algorithm testing.

Conclusions:

  • AI holds significant potential for improving glaucoma assessment, but clinical usability is limited.
  • Key challenges include data scarcity, lack of diagnostic consensus, and the need for multimodal AI approaches.
  • Further research is essential to overcome these hurdles and develop robust, clinically applicable AI tools for glaucoma management.